Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
BoldRose Capital is a venture capital firm based in Greenwich, Connecticut, founded to provide strategic capital and partnership across various industries. The firm primarily focuses on the cannabis sector, investing in companies involved in data & analysis, distribution & logistics, consumer packaged goods, and ancillary cannabis products. Established with a vision to collaborate closely with operating teams, BoldRose aims to foster growth and operational excellence within its portfolio.
As of now, BoldRose Capital manages a portfolio of 17 companies, with a notable emphasis on the cannabis industry. The firm operates under the dual identity of BoldRose Capital and Boldrose Management Group LLC, the latter being a registered investment adviser with the SEC. This structure allows them to manage outside capital effectively while maintaining a focus on high-net-worth individuals and family offices as their primary limited partners.
BoldRose Capital has made significant strides since its inception, with a history of successful investments and exits. The firm is headquartered at 177 West Putnam Ave, Greenwich, CT, and continues to evolve its investment strategy to adapt to the changing landscape of the cannabis market.
BoldRose Capital specializes in the cannabis sector, focusing on a range of investment stages including Seed, Series A, Series B, and Growth Equity. The firm seeks to partner with innovative companies that operate within the cannabis industry, particularly those involved in data & analysis, distribution & logistics, consumer packaged goods, and ancillary cannabis products. Their investment strategy emphasizes operational partnerships, allowing them to leverage their expertise to drive growth and navigate the complexities of the cannabis market.
The firm typically invests in the United States, aligning its geographic focus with the evolving regulatory landscape of cannabis. While specific check sizes are not disclosed, BoldRose Capital has a history of participating in significant funding rounds, such as Eaze's $13 million Series B round. Their approach to capital deployment is comprehensive, ensuring that they support companies at various stages of their growth journey.
BoldRose Capital has built a diverse portfolio of 17 companies, primarily within the cannabis sector. Notable investments include:
In addition to these highlighted companies, BoldRose Capital has a total of four confirmed exits, showcasing their ability to identify and support successful ventures within the cannabis industry.
Andrew Schweibold - Co-Founder & CEO. Andrew has extensive experience in venture capital and has led multiple successful investments in the cannabis sector. His background includes working with high-net-worth individuals and family offices, providing him with a deep understanding of capital deployment strategies.
Arin Aragona - Co-Founder/Partner. Arin brings a wealth of knowledge in operational management and strategic partnerships. His expertise lies in guiding cannabis companies through the complexities of growth and regulatory challenges.
To pitch BoldRose Capital, founders should send an email to info@boldrosecapital.com. It is recommended to include a comprehensive pitch deck that outlines the business model, market opportunity, and financial projections. While there is no formal application portal, a well-structured email can facilitate initial discussions.
Response times may vary, but founders should expect to hear back within a few weeks. Warm introductions can enhance the chances of a timely response, especially from individuals within their network.
In June 2022, BoldRose Capital made its last confirmed investment in Danbury Car Care, indicating a potential shift in focus beyond cannabis. Prior to this, the firm had concentrated its efforts on cannabis operators, with significant activity noted between 2016 and 2022.
As of now, there have been no reported investments or exits in 2023 or 2024, suggesting a slowdown in their investment pace. The firm continues to monitor the cannabis market for opportunities that align with its investment thesis.
What are BoldRose Capital's investment criteria?
BoldRose Capital focuses on the cannabis sector, investing in companies involved in data & analysis, distribution & logistics, consumer packaged goods, and ancillary cannabis products. They look for innovative companies that demonstrate growth potential and operational excellence.
How can I pitch to BoldRose Capital?
Founders can reach out to BoldRose Capital via email at info@boldrosecapital.com. It is advisable to include a detailed pitch deck that outlines the business model, market opportunity, and financial projections.
What makes BoldRose Capital different from other investors?
BoldRose Capital specializes in the cannabis sector, providing not only capital but also operational support and strategic partnerships. Their deep understanding of the cannabis industry allows them to guide portfolio companies effectively.
What is the geographic scope of BoldRose Capital's investments?
The firm primarily invests in the United States, aligning its focus with the evolving regulatory landscape of the cannabis market.
What is the typical check size for investments?
While specific check sizes are not publicly disclosed, BoldRose Capital has participated in significant funding rounds, such as Eaze's $13 million Series B. The firm is likely to consider various check sizes depending on the stage and needs of the company.
What kind of post-investment involvement can founders expect?
BoldRose Capital adds value through strategic partnerships and operational support, helping portfolio companies navigate the complexities of the cannabis industry. Their network includes high-net-worth individuals and family offices, providing additional resources for growth.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.